This study analyzes the US enzyme industry. It presents historical demand data for the years 1999, 2004 and 2009, and forecasts for 2014 and 2019 by market (e.g., pharmaceuticals, starch processing, research and biotechnology, food and beverage processing, cleaning products, diagnostics, animal feed), and product (e.g., carbohydrases, proteases, polymerases, nucleases, lipases). The study also considers market environment factors, details industry structure, evaluates company market share and profiles industry competitors.

US retail spending on pet health products and services will rise 6.5 percent annually through 2014. Pet insurance will be the fastest growing service from a small base. Pharmaceuticals recently became the largest product category--surpassing parasiticides--and will be among the fastest growing, second only to dietary supplements.

US demand for vaccines will advance 5.6 percent annually through 2014, driven by the development of new vaccines to treat complex human diseases, such as cancer. Public health recommendations for adult and adolescent immunization will produce continued strong sales in this segment, which has reached the level of pediatric vaccines sales.

US demand for nanosized medical products will grow 17.1 percent annually through 2014. Cancer and central nervous system disorders will be the fastest growing applications. Nanomedicines will provide the best opportunities, while nanotech medical supplies and devices grow the fastest from a small base.

US food safety product demand will rise 6.7 percent annually through 2014, driven by food safety concerns and regulations. The food and beverage processing market will remain dominant, led by the beverage segment. Disinfection and diagnostic products will continue as the most common types, while smart labels and tags will see the fastest growth.

Global wound management product demand will rise 4.6 percent yearly through 2013. Best growth prospects include tissue sealants, foam and alginate wound dressings, growth factors, bioengineered tissue substitutes and anti-adhesion agents. China will be the fastest growing market, while the US remains the largest.

Global nutraceutical ingredient demand will rise 6.2 percent annually through 2013. China and India will be the fastest growing national markets while the US remains the largest. Best prospects include soy proteins; additives lutein and lycopene; vitamins A and E; minerals calcium and magnesium; and extracts ginkgo biloba and glucosamine.

US soy chemical demand will grow 7.8 percent annually through 2013, driven by the continued penetration of biodiesel, and by the adoption of alternatives to traditional, petrochemical-based materials in manufacturing. Soy oil derivatives such as methyl soyate, polyols, soy-based foamed plastics, waxes and fatty acids hold particularly good prospects.

Global enzyme demand will rise 6.3 percent annually through 2013, driven by strong demand in the specialty enzymes segment and good growth in animal feed and ethanol markets. North America and Western Europe will see healthy market gains while the fastest growth remains in developing countries.

Food safety product demand in China will grow 15 percent annually through 2013. Growth will be driven by ongoing food and beverage output gains, especially processed items, and more focus on food safety and supply chain security. Disinfection products will remain the largest segment while tracking products grow the fastest.